AUPH - Aurinia Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

AUPH is currently covered by 3 analysts with an average potential upside of $9.2 (75.15%) from yesterday's end of day stock price of $8.86. Aurinia Pharmaceuticals activity chart has currently 26 price targets and 39 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.55% with an average time for these price targets to be met of 293 days.

Highest price target for AUPH is $20, Lowest price target is $4, average price target is $12.

Most recent stock forecast was given by ED ARCE from HCWAINWRIGHT on 22-Sep-2023. First documented stock forecast 21-Apr-2017.

Best performing analysts who are covering AUPH - Aurinia Pharmaceuticals:

Alethia Young Justin Kim Douglas Miehm Joseph Schwartz Ed Arce Ken Cacciatore Elemer Piros

Currently, out of the existing stock ratings of AUPH - 13 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

15

$7.23 (93.05%)

15

2 months 18 days ago

0/5 (0%)

$11.39 (110.97%)

Buy

11

$2.14 (24.15%)

11

9 months 17 days ago

6/10 (60%)

$2.6 (30.95%)

135

Buy

13

1 years 1 months 6 days ago

3/7 (42.86%)

$4.73 (57.19%)

91

Buy

1 years 1 months 6 days ago

0/1 (0%)

$4.61 (15.17%)

Buy

35

$27.23 (350.45%)

30

2 years 4 months 4 days ago

1/2 (50%)

$17.83 (121.90%)

326

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?

On average it took 293 days on average for the stock forecasts to be realized with a an average price target met ratio 47.55

Which analyst has the current highest performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

ALETHIA YOUNG

Which analyst has the current lower performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?

Alethia Young works at CANTOR FITZGERALD and has 0 price targets and 0 ratings on AUPH

Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?

Ken Cacciatore with highest potential upside - $27.23

Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?

Justin Kim with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart